The Claim
Consumption of milk containing A1 β-casein in post-weaned rats is associated with region-specific alterations in μ-opioid receptor binding in the somatosensory cortex, hypothalamus, and amygdala, which are distinct from alterations observed with A2 β-casein or casein-free diets.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In post-weaned rats, milk with A1 β-casein changes μ-opioid receptor binding in specific brain regions differently than milk with A2 β-casein or diets without casein.
See the scientific wording
In post-weaned rats, consumption of milk containing A1 β-casein is associated with region-specific alterations in μ-opioid receptor binding in the somatosensory cortex, hypothalamus, and amygdala, distinct from changes seen with A2 β-casein or casein-free diets.
When a rat drinks milk with A1 β-casein, its gut breaks it down into a peptide called BCM-7. This peptide enters the bloodstream, passes into the brain, and binds to μ-opioid receptors in areas that control mood and stress. This binding changes how many receptors are present in the somatosensory cortex, hypothalamus, and amygdala, which disrupts normal emotional signaling and leads to passive stress responses. Milk with A2 β-casein does not produce BCM-7, so it does not trigger these brain changes.
What the research says
1 studyRats that drank milk with A1 protein showed different brain changes linked to mood and stress than rats that drank milk with A2 protein — suggesting A1 might affect the brain in a unique way.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.